PLUVICTO
NDC 0078-1217, lutetium Lu 177 vipivotide tetraxetan, injection, solution, from Novartis Pharmaceuticals Corporation.
- Product NDC
- 0078-1217
- Status
- Listed
- Labeler
- Novartis Pharmaceuticals Corporation
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA215833
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0078-1217 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN27 mCi/mL
Pharmacologic classes
Radioligand Activity [MoA]; Radioligand Therapeutic Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0078-1217-61 | 00078121761 | 1 VIAL, GLASS in 1 PACKAGE (0078-1217-61) / 7.5 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/14908037-2892-4d98-a053-253ce35afb1a
Use it
Look up 0078-1217 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0078-1217 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0078-1217. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.